Western University of Health Sciences Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2018
NCT03946085
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Western University of Health Sciences

Active Ingredients

Drugs in Other Trials (3)

carotenoid (1 trial)

multivitamins (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3